The SISAQOL-IMI consortium, co-led by the European Organization for Research and Treatment of Cancer (EORTC) and Boehringer Ingelheim (BI), has published a paper in The Lancet Oncology outlining how ...
Debra Patt, MD, PhD, MBA, discusses how the implementation of electronic patient-reported outcomes is changing cancer care.
The SISAQOL-IMI consortium, co-led by the European Organisation for Research and Treatment of Cancer (EORTC) and Boehringer Ingelheim (BI), just announced the publication of its pivotal paper in The ...
A large multinational clinical trial has found that giving healthcare providers access to European Organisation for Research and Treatment of Cancer (EORTC) patient-reported outcome (PRO) data ...
Access to patient-reported outcome (PRO) data significantly improved providers' consistency in assessing adverse events in patients with cancer, with the greatest improvements observed for ...
The pretreatment evaluation of patient-reported, health-related quality of life provides valuable prognostic information on ...
Oncology trial design is being rewritten in real time, and protocols written even 12 months ago are starting to look out of ...
The center-specific survival analysis annually assigns all hematopoietic cell transplantation (HCT) centers in the United States a +1, −1, or 0 score for observed outcomes that are above, below, or ...
Morning Overview on MSN
Daraxonrasib nearly doubled survival in metastatic pancreatic cancer, cutting the risk of death by 60% in a 500-patient trial
Patients with previously treated metastatic pancreatic cancer lived roughly twice as long on a daily oral drug called ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results